Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 10331908

Polymethylmethacrylate-based bone cement modified with hydroxyapatite.

C I Vallo·P E Montemartini·M A Fanovich·J M Porto López·T R Cuadrado
View original source ↗Export metadata ↓

Abstract

A commercial acrylic bone cement was modified by the incorporation of different weight fractions of polycrystalline hydroxyapatite (HA), and the modified formulation was investigated. The influence of the filler proportion on the flow characteristics and the mechanical behavior of the resultant composite was evaluated. The residual monomer present in the cured materials was measured by gas chromatography. The comparison of the residual monomer present in the cements with and without reinforcement demonstrated that the degree of polymerization was not affected by the addition of HA. Porosity morphology was analyzed by optical and scanning electron microscopy. Image examination revealed that the porosity and the pore size of the hardened cement increased with an increasing amount of particulate filler. Flexural, compressive, and fracture properties of the cement with varying amounts of HA reinforcement were measured. It was found that up to 15 wt% HA could be added for increases in flexural modulus and fracture toughness. HA acts as a rigid filler that enhances fracture resistance and flexural modulus. Our results show that the workability of the modified formulation limited the incorporation of the ceramic filler to a maximum value of 15 wt%.

Explore related subjects

Biocompatible MaterialsBone CementsHydroxyapatitesMicroscopy, Electron, ScanningPolymethyl MethacrylatePorosityJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

C I Vallo, P E Montemartini, M A Fanovich, J M Porto López, T R Cuadrado. 1999. Polymethylmethacrylate-based bone cement modified with hydroxyapatite.. https://doi.org/10.1002/(sici)1097-4636(1999)48%3A2%3C150%3A%3Aaid-jbm9%3E3.0.co%3B2-d

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2001

Chemotactic penetration of keratocytes in ePTFE polymer in vitro.

Expanded polytetrafluoroethylene (ePTFE) is used as a support for artificial corneas. Implanted in corneas, most of the time this polymer is colonized by corneal host cells. The absence of colonization often coincides with extrusion of the polymer. Therefore, we decided to introduce keratocytes into ePTFE in vitro before implantation. Because keratocytes do not spontaneously enter ePTFE, we used several chemoattractants, separately and in a mixture, to stimulate the penetration of cultured keratocytes into the polymer. The influence of the passage number on cell penetration was also studied. No significant differences were observed up to the seventh passage, although seventh-passage cells penetrated somewhat more slowly than younger cells. Satisfactory results were obtained with four of the tested chemotactic factors: IL-6, type alpha transforming growth factor (TGF-alpha), platelet derived growth factor isoform BB (PDGF-BB), and fibroblast growth factor-2 (FGF-2). Under our experimental conditions, two to more than six million keratocytes entered the polymer discs with a volume of 706.5 mm(3) in the presence of these four chemoattractants. TGF-alpha was the most efficient and was selected for further in vitro and in vivo studies.

Biocompatible Materials↗
PubMed2001

Fabrication of porous calcium polyphosphate implants by solid freeform fabrication: a study of processing parameters and in vitro degradation characteristics.

Solid freeform fabrication (SFF) involves the creation of a solid 3-D object of desired shape by successively adding raw materials in particles or layers. Its use in fabricating surgical implants is being explored. The objective of this study was to determine the feasibility of using SFF to build porous parts of calcium polyphosphate (CPP), a linear condensed phosphate that has been suggested as a material for forming bioresorbable skeletal replacement implants. CPP powders (<25 microm in particle size) were added to an UV curable monomer (SOMOS 6110) at a solids loading of 25 vol %, with the addition of a commercial dispersant to prevent particle agglomeration and settling. Viscosity and cure depth measurements were performed to insure that CPP suspension met the requirements deemed necessary for use in SFF. The CPP suspension was bulk cured and sintered in molds in order to assess binder removal and sintering parameters. Using a three-point bend test, the ultimate bending strength and energy-to-fracture of sintered CPP samples simulating parts to be formed by this strategy were characterized. In vitro degradation studies using 0.1M of tris-buffered solution were performed to assess the effect of aging on mechanical properties of the samples as a function of the processing route and resulting structures. The polymer binder successfully was removed from the cured ceramic suspension by developing a procedure that combined slow heating rates with low temperature dwells. Sintering CPP at 585 degrees C for 1 h produced amorphous material samples with average porosity of 27.7 +/- 2.0%. Sintering CPP at 600 degrees C for 1 h produced a crystalline material with samples having an average porosity of 22.9 +/- 1.3%. Crystalline CPP was found to exhibit superior bend strength and toughness compared with amorphous CPP. Both samples experienced a decline in mechanical properties during in vitro degradation; however, the effects were more pronounced with the amorphous CPP samples. Amorphous CPP was found to degrade four times faster than crystalline CPP, as shown by high levels of phosphate present in the degradation solution and a noticeable increase in the porosity of the samples. Crystalline CPP was more resistant to attack as dissolution was limited to surface features of the sintered particles.

Biocompatible Materials↗
PubMed2001

Enzyme-induced biodegradation of polycarbonate polyurethanes: dependence on hard-segment concentration.

Polycarbonate-based polyurethanes with varying hard segment contents were synthesized. The physical and chemical structures were characterized by using gel permeation chromatography, differential scanning calorimetry, water uptake testing, Fourier transform infrared, and attenuated total reflectance--Fourier transform infrared. The polymers were incubated with cholesterol esterase in a phosphate buffer solution at 37 degrees C over 10 weeks. A higher resistance to hydrolytic degradation was observed in polycarbonate-based urethanes with higher hard segment content. The analysis of the material structures revealed that the degradation of polycarbonate-based urethanes was preferentially initiated at non-hydrogen-bonded carbonates and urethanes. Although the crystallinity of the polycarbonate soft segment may contribute to reducing the hydrolytic degradation catalyzed by cholesterol esterase, it was found to be relatively minor in comparison to the importance of hydrogen bonding between the carbonate and urethane groups. These observations suggest that the biostability of polyurethanes and specifically polycarbonate-based polyurethanes can be improved by manipulating the degree of hydrogen bonding within the materials.

Biocompatible Materials↗